secwatch / observer
8-K filed April 25, 2025, 7:59 PM ET ticker OCGN CIK 0001372299
leadership confidence high sentiment neutral materiality 0.45

Ocugen board to replace Drs. Fernandes and Whittington at 2025 annual meeting

Ocugen, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Blaise Coleman

Director
OCGN · Ocugen, Inc.
Filed
April 25, 2025, 7:59 PM ET
The Board plans to nominate Satish Chandran, Ph.D. and Blaise Coleman for election to the Board at the 2025 Annual Meeting to replace Dr. Fernandes and Dr. Whittington.
Departed

Marna C. Whittington

Director
OCGN · Ocugen, Inc.
Filed
April 25, 2025, 7:59 PM ET
Separately, on April 21, 2025, Marna C. Whittington, Ph.D., a member of the Board, the Compensation Committee of the Board, and a member and chair of the Audit Committee of the Board, informed the Company of her decision to not stand for re-election to the Board at the Company’s 2025 Annual Meeting.
Departed

Prabha Fernandes

Director
OCGN · Ocugen, Inc.
Filed
April 25, 2025, 7:59 PM ET
Prabha Fernandes, Ph.D., FIDSA, a member of the Board of Directors (the “Board”) of Ocugen, Inc. (the “Company”), a member and chair of the Compensation Committee of the Board, a member of the Audit Committee of the Board and the Science and Technology Committee of the Board, informed the Company that she is resigning from the Board effective at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
Appointed

Satish Chandran

Director
OCGN · Ocugen, Inc.
Filed
April 25, 2025, 7:59 PM ET
The Board plans to nominate Satish Chandran, Ph.D. and Blaise Coleman for election to the Board at the 2025 Annual Meeting to replace Dr. Fernandes and Dr. Whittington.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.85

Blaise Coleman was appointed as Director at Ocugen, Inc..

Action
nominated
Role
Director
Exact text from the filing
The Board plans to nominate Satish Chandran, Ph.D. and Blaise Coleman for election to the Board at the 2025 Annual Meeting to replace Dr. Fernandes and Dr. Whittington.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Marna C. Whittington departed as Director at Ocugen, Inc..

Action
not stand for re-election
Role
Director
Exact text from the filing
Separately, on April 21, 2025, Marna C. Whittington, Ph.D., a member of the Board, the Compensation Committee of the Board, and a member and chair of the Audit Committee of the Board, informed the Company of her decision to not stand for re-election to the Board at the Company’s 2025 Annual Meeting.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Prabha Fernandes resigned as Director at Ocugen, Inc..

Action
resigned
Role
Director
Exact text from the filing
Prabha Fernandes, Ph.D., FIDSA, a member of the Board of Directors (the “Board”) of Ocugen, Inc. (the “Company”), a member and chair of the Compensation Committee of the Board, a member of the Audit Committee of the Board and the Science and Technology Committee of the Board, informed the Company that she is resigning from the Board effective at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.85

Satish Chandran was appointed as Director at Ocugen, Inc..

Action
nominated
Role
Director
Exact text from the filing
The Board plans to nominate Satish Chandran, Ph.D. and Blaise Coleman for election to the Board at the 2025 Annual Meeting to replace Dr. Fernandes and Dr. Whittington.
View on SEC.gov

Ocugen, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-25-039478
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.